Epidermolysis bullosa (EB) is a rare genetic skin disorder that causes extreme skin fragility, leading to recurrent blister formation with even minor trauma. There are three major forms of EB: EB simplex (EBS), Junctional EB (JEB), and Dystrophic EB (DEB). Each type of EB differs in severity and clinical presentation. Caring for all patients with EB requires a multidisciplinary approach.

What is Epidermolysis Bullosa?

Find out on our EB Facts page, or for more detailed information please refer to this online Epidermolysis Bullosa Medscape chapter.

EB Clinic Overview

Our outpatient Epidermolysis Bullosa Clinic occurs once a month, usually on the third Friday of the month and is directed byDr. Phuong Khuu. The clinic is staffed by highly skilled pediatric specialists, experienced in the care of children with epidermolysis bullosa. If you are a physician and would like to refer a child to our EB Clinic, download a Consultation Request. (PDF)

Pediatric EB Clinic Link: http://med.stanford.edu/dermatology/resources/gsdc/eb_clinic/eb-clinic-overview.html

Adult EB patients 18 and older are seen by Dr. Peter Marinkovich who directs the Stanford Blistering Disease Clinic, to refer an adult EB patient to this clinic, please contact Sabrina Hwee at SHwee@stanfordhealthcare.org.

Adult EB Clinic Link: https://stanfordhealthcare.org/medical-clinics/blistering-disease-clinic.html  

EB Research at Stanford

Research at Stanford University School of Medicine's Department of Dermatology is funded by the National Institutes of Health, the Stanford SPARK program, the Epidermolysis Bullosa Medical Research Foundation (EBMRF), and the Epidermolysis Bullosa Research Partnership (EBRP). Research is directed at developing new molecular therapies for EB.

EB Clinical Trials

We have completed phase 1 of our keratinocyte gene therapy study for recessive dystrophic epidermolysis bullosa and are recruiting patients for phase 2 of the trial.

Our phase I clinical trial of fibroblast gene therapy for recessive dystrophic epidermolysis bullosa is currently ongoing and we are recruiting patients for this trial.

Click on the link above for a complete list and information on current Stanford clinical trials.

EB Patient Resources

Helpful links for more information about epidermolysis bullosa.

EB Physician Resources